Follow
Darragh McArt
Darragh McArt
Verified email at qub.ac.uk
Title
Cited by
Cited by
Year
QuPath: Open source software for digital pathology image analysis
P Bankhead, MB Loughrey, JA Fernández, Y Dombrowski, DG McArt, ...
Scientific reports 7 (1), 1-7, 2017
44982017
Digital pathology and image analysis in tissue biomarker research
PW Hamilton, P Bankhead, Y Wang, R Hutchinson, D Kieran, DG McArt, ...
Methods 70 (1), 59-73, 2014
2212014
Challenging the cancer molecular stratification dogma: intratumoral heterogeneity undermines consensus molecular subtypes and potential diagnostic value in colorectal cancer
PD Dunne, DG McArt, CA Bradley, PG O'Reilly, HL Barrett, R Cummins, ...
Clinical Cancer Research 22 (16), 4095-4104, 2016
1602016
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ...
EBioMedicine 31, 182-189, 2018
1362018
EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer
PD Dunne, S Dasgupta, JK Blayney, DG McArt, KL Redmond, JA Weir, ...
Clinical Cancer Research 22 (1), 230-242, 2016
1312016
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis
CM McCourt, DG McArt, K Mills, MA Catherwood, P Maxwell, DJ Waugh, ...
PLoS One 8 (7), e69604, 2013
1292013
AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
PD Dunne, DG McArt, JK Blayney, M Kalimutho, S Greer, T Wang, ...
Clinical Cancer Research 20 (1), 164-175, 2014
1142014
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
P Bankhead, JA Fernández, DG McArt, DP Boyle, G Li, MB Loughrey, ...
Laboratory investigation 98 (1), 15-26, 2018
1032018
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
PD Dunne, M Alderdice, PG O'Reilly, AC Roddy, AMB McCorry, ...
Nature communications 8 (1), 15657, 2017
892017
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
S Jain, CA Lyons, SM Walker, S McQuaid, SO Hynes, DM Mitchell, ...
Annals of Oncology 29 (1), 215-222, 2018
852018
QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017; 7: 16878
P Bankhead, MB Loughrey, JA Fernández, Y Dombrowski, DG McArt, ...
CHAPTER, 2022
802022
Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer
JS Riley, R Hutchinson, DG McArt, N Crawford, C Holohan, I Paul, ...
Cell death & disease 4 (12), e951-e951, 2013
782013
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
DP Boyle, DG McArt, G Irwin, CS Wilhelm‐Benartzi, TF Lioe, E Sebastian, ...
Histopathology 65 (3), 340-352, 2014
702014
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy
WL Allen, PD Dunne, S McDade, E Scanlon, M Loughrey, HG Coleman, ...
JCO precision oncology 2, 1-15, 2018
662018
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
M Alderdice, SD Richman, S Gollins, JP Stewart, C Hurt, R Adams, ...
The Journal of pathology 245 (1), 19-28, 2018
632018
Automated tumor analysis for molecular profiling in lung cancer
PW Hamilton, Y Wang, C Boyd, JA James, MB Loughrey, JP Hougton, ...
Oncotarget 6 (29), 27938, 2015
602015
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
RA Hutchinson, RA Adams, DG McArt, M Salto-Tellez, B Jasani, ...
Journal of translational medicine 13, 1-11, 2015
592015
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
NE Buckley, C Forde, DG McArt, DP Boyle, PB Mullan, JA James, ...
Scientific reports 6 (1), 23383, 2016
572016
QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017; 7 (1): 16878
P Bankhead, MB Loughrey, JA Fernandez, Y Dombrowski, DG McArt, ...
Journal for ImmunoTherapy of Cancer (JITC) preprint. The copyright holder …, 0
57
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
SG Craig, MP Humphries, M Alderdice, V Bingham, SD Richman, ...
British journal of cancer 123 (8), 1280-1288, 2020
562020
The system can't perform the operation now. Try again later.
Articles 1–20